Orange Book product · Brand (NDA)
ESKALITH CR
LITHIUM CARBONATE
At a glance
Mar 29, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 29, 1982
44 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
LITHIUM CARBONATE
Strength
450MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 018152
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1987LITHIUM CARBONATEBrand (NDA)
NDA 017812 · HIKMA
- 1985LITHANEBrand (NDA)
NDA 018833 · BAYER PHARMS
- 1982LITHIUM CARBONATEBrand (NDA)
NDA 018558 · HIKMA
- —ESKALITHBrand (NDA)
NDA 016860 · NOVEN THERAP
- —LITHONATEBrand (NDA)
NDA 016782 · SOLVAY
- —LITHOBIDBrand (NDA)
NDA 018027 · ANI PHARMS
- —ESKALITHBrand (NDA)
NDA 017971 · JDS PHARMS
- —LITHIUM CARBONATEBrand (NDA)
NDA 016834 · PFIZER
- —LITHOTABSBrand (NDA)
NDA 016980 · SOLVAY
- 2017LITHIUM CARBONATEGeneric (ANDA)
ANDA 205663 · UNIQUE
- 2016LITHIUM CARBONATEGeneric (ANDA)
ANDA 205532 · HERITAGE PHARMA
- 2015LITHIUM CARBONATEGeneric (ANDA)
ANDA 204779 · UNIQUE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
